Digital platform • AI for pharmacovigilance & real‑world evidence

Safer, more effective medicines—across every population and condition.

PharmaAI analyzes how medications perform in the real world across different populations, environments, and clinical contexts—so teams can detect safety signals earlier, refine effectiveness insights, and improve access.

Signal detection
Earlier identification of potential adverse events
Subgroup insights
Performance by age, sex, comorbidities, genomics, geography
Access intelligence
Barriers, affordability, and availability signals
Safety & Effectiveness Monitor
Medication
ExampleDrug XR
Population
Older adults (65+)
Potential signal Updated weekly

Higher than expected reports of hypotension when co‑administered with diuretics in hot climates.

ROR
1.8
Confidence
Medium
Suggested action
Review label & guidance
EHR / claims Registries Spontaneous reports Literature Weather / environment

Prototype visualization for demonstration only. Not medical advice.

What PharmaAI does

A unified platform to improve drug safety, effectiveness, and access with evidence you can audit.

Drug safety intelligence

Detect and triage potential safety signals using AI‑assisted case processing, de‑duplication, and disproportionality analytics—then route investigations to the right teams.

  • Signal scoring with uncertainty and rationale
  • Population & co‑medication stratification
  • Explainable summaries for review

Effectiveness in the real world

Combine real‑world data (EHR, claims, registries, digital health) with literature evidence to understand how benefits and risks vary by context.

  • Confounding‑aware cohort comparisons
  • Outcome definitions you can version
  • Reproducible pipelines

Access & equity analytics

Identify where people can’t get the right medicine—because of supply, cost, geography, or policy—and measure downstream clinical impact.

  • Availability and affordability indicators
  • Geospatial access mapping
  • Equity dashboards by subgroup

Products & Service Features

Core modules and implementation services that help teams improve safety, effectiveness, and access.

Product: Safety Signal Studio

Detect, triage, and investigate potential safety signals with audit-ready outputs.

InputsSpontaneous reports, call centers, literature, EHR
OutputsSignal briefs, monitoring reports, case narratives
ControlsRole‑based access, audit trails, review queues

Product: Population Insights

Analyze medication performance across demographics, comorbidities, geography, and environment.

StratifyPregnancy, renal/hepatic impairment, pediatrics, geriatrics
ContextHeat, altitude, seasonality, infectious outbreaks
ResultActionable guidance for clinicians & labels

Product: RWE Workbench

Run reproducible cohort and outcomes analyses to support monitoring and decision-making.

DesignCohorts, external controls, pragmatic analyses
GovernData provenance, versioning, reproducibility
SharePublishable evidence packs

Service Feature: Access & Equity Analytics

Identify access barriers (cost, supply, geography) and track equity impacts over time.

MonitorDispensing patterns, stockouts, price signals
TargetRegions and subgroups most affected
ActPolicy and distribution interventions

How it works

A modern evidence stack: ingest → standardize → analyze → explain → act.

1

Ingest

Connect EHR/claims, registries, safety reports, and literature—plus optional environment layers.

2

Standardize

Normalize terminology and structure to support consistent analytics and cross‑source comparisons.

3

Analyze

Run safety signal detection, subgroup analyses, and RWE workflows with reproducible pipelines.

4

Explain

Generate audit‑ready briefs: what changed, for whom, under what conditions, and why.

5

Act

Route to review queues, create monitoring plans, and track outcomes over time.

Responsible AI by design

PharmaAI is built for high‑stakes decisions: human‑in‑the‑loop review, audit trails, and transparent uncertainty—so teams can trust and verify outputs.

Audit logs & provenance
Bias & subgroup monitoring
Security & access controls
Model cards & change tracking

Request a demo

Tell us what you’re trying to improve—safety operations, effectiveness insight, or access equity.

LocationGlobal • Remote‑first
FocusPharmacovigilance • RWE • Health equity